Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration

Journal of Physiology

Volumn 593, Issue 11, 2015, Pages 2479-2497

  Cohen, Tatiana V ^a,b   Kollias, Helen D ^a   Liu, Naili ^a   Ward, Christopher W ^c   Wagner, Kathryn R ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSTATIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; SMAD7 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXON; FEMALE; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GENE DISRUPTION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MALE; MUSCLE CELL; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE INJURY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STRENGTH; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; INJURIES; KNOCKOUT MOUSE; MUSCLE DEVELOPMENT; PHYSIOLOGY; REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; MALE; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOBLASTS; REGENERATION; SMAD7 PROTEIN;

EID: 84929896576     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270201     Document Type: Article

References (68)

1. Acuna MJ, Pessina P, Olguin H, Cabrera D, Vio CP, Bader M, Munoz-Canoves P, Santos RA, Cabello-Verrugio C & Brandan E (2014). Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling. Hum Mol Genet 23, 1237-1249.
2. Allen DL & Unterman TG (2007). Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 292, C188-C199.
3. Amthor H & Hoogaars WM (2012). Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy. Curr Gene Ther 12, 245-259.
4. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L & Patel K (2007). Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 104, 1835-1840.
5. Amthor H, Otto A, Vulin A, Rochat A, Dumonceaux J, Garcia L, Mouisel E, Hourde C, Macharia R, Friedrichs M, Relaix F, Zammit PS, Matsakas A, Patel K & Partridge T (2009). Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Natl Acad Sci USA 106, 7479-7484.
6. Attie KM, Borgstein NG, Yang Y, Condon CH, Wilson DM, Pearsall AE, Kumar R, Willins DA, Seehra JS & Sherman ML (2013). A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve 47, 416-423.
7. Bish LT, Sleeper MM, Forbes SC, Morine KJ, Reynolds C, Singletary GE, Trafny D, Pham J, Bogan J, Kornegay JN, Vandenborne K, Walter GA & Sweeney HL (2011). Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Hum Gene Ther 22, 1499-1509.
8. Bo Li Z, Zhang J & Wagner KR (2012). Inhibition of myostatin reverses muscle fibrosis through apoptosis. J Cell Sci 125, 3957-3965.
9. Bobinac D, Malnar-Dragojevic D, Bajek S, Soic-Vranic T & Jerkovic R (2000). Muscle fiber type composition and morphometric properties of denervated rat extensor digitorum longus muscle. Croat Med J 41, 294-297.
10. Briones-Orta MA, Tecalco-Cruz AC, Sosa-Garrocho M, Caligaris C & Macias-Silva M (2011). Inhibitory Smad7: emerging roles in health and disease. Curr Mol Pharmacol 4, 141-153.
11. Brooks SV & Faulkner JA (1988). Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404, 71-82.
12. Burks TN & Cohn RD (2011). Role of TGF-beta signaling in inherited and acquired myopathies. Skelet Muscle 1, 19.
13. Carlson ME, Hsu M & Conboy IM (2008). Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454, 528-532.
14. Carraro U, Dalla Libera L & Catani C (1983). Myosin light and heavy chains in muscle regenerating in absence of the nerve: transient appearance of the embryonic light chain. Exp Neurol 79, 106-117.
15. Cohen TV, Cohen JE & Partridge TA (2012). Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response. Neuromuscul Disord 22, 648-658.
16. Cohen TV, Gnocchi VF, Cohen JE, Phadke A, Liu H, Ellis JA, Foisner R, Stewart CL, Zammit PS & Partridge TA (2013). Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2alpha. Hum Mol Genet 22, 2852-2869.
17. Cohen TV, Klarmann KD, Sakchaisri K, Cooper JP, Kuhns D, Anver M, Johnson PF, Williams SC, Keller JR & Stewart CL (2008). The lamin B receptor under transcriptional control of C/EBPepsilon is required for morphological but not functional maturation of neutrophils. Hum Mol Genet 17, 2921-2933.
18. Cohn RD, vanErp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW & Dietz HC (2007). Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13, 204-210.
19. Conboy IM & Rando TA (2012). Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches. Cell Cycle 11, 2260-2267.
20. Dorsey SG, Lovering RM, Renn CL, Leitch CC, Liu X, Tallon LJ, Sadzewicz LD, Pratap A, Ott S, Sengamalay N, Jones KM, Barrick C, Fulgenzi G, Becker J, Voelker K, Talmadge R, Harvey BK, Wyatt RM, Vernon-Pitts E, Zhang C, Shokat K, Fraser-Liggett C, Balice-Gordon RJ, Tessarollo L & Ward CW (2012). Genetic deletion of trkB.T1 increases neuromuscular function. Am J Physiol Cell Physiol 302, C141-C153.
21. Girgenrath S, Song K & Whittemore LA (2005). Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve 31, 34-40.
22. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA, Jr., Wrana JL & Falb D (1997). The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165-1173.
23. Hennebry A, Berry C, Siriett V, O'Callaghan P, Chau L, Watson T, Sharma M & Kambadur R (2009). Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression. Am J Physiol Cell Physiol 296, C525-C534.
24. Holzbaur EL, Howland DS, Weber N, Wallace K, She Y, Kwak S, Tchistiakova LA, Murphy E, Hinson J, Karim R, Tan XY, Kelley P, McGill KC, Williams G, Hobbs C, Doherty P, Zaleska MM, Pangalos MN & Walsh FS (2006). Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis 23, 697-707.
25. Hughes SM, Taylor JM, Tapscott SJ, Gurley CM, Carter WJ & Peterson CA (1993). Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development 118, 1137-1147.
26. Huguet A, Medja F, Nicole A, Vignaud A, Guiraud-Dogan C, Ferry A, Decostre V, Hogrel JY, Metzger F, Hoeflich A, Baraibar M, Gomes-Pereira M, Puymirat J, Bassez G, Furling D, Munnich A & Gourdon G (2012). Molecular, physiological, and motor performance defects in DMSXL mice carrying > 1000 CTG repeats from the human DM1 locus. PLoS Genet 8, e1003043.
27. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M & Miyazono K (1997). Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389, 622-626.
28. Jeong J, Conboy MJ & Conboy IM (2013). Pharmacological inhibition of myostatin/TGF-beta receptor/pSmad3 signaling rescues muscle regenerative responses in mouse model of type 1 diabetes. Acta Pharm Sinic 34, 1052-1060.
29. Kollias HD, Perry RL, Miyake T, Aziz A & McDermott JC (2006). Smad7 promotes and enhances skeletal muscle differentiation. Mol Cell Biol 26, 6248-6260.
30. Kota J, Handy CR, Haidet AM, Montgomery CL, Eagle A, Rodino-Klapac LR, Tucker D, Shilling CJ, Therlfall WR, Walker CM, Weisbrode SE, Janssen PM, Clark KR, Sahenk Z, Mendell JR & Kaspar BK (2009). Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med 1, 6ra15.
31. Lach-Trifilieff E, Minetti GC, Sheppard K, Ibebunjo C, Feige JN, Hartmann S, Brachat S, Rivet H, Koelbing C, Morvan F, Hatakeyama S & Glass DJ (2014). An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol 34, 606-618.
32. Lee SJ (2004). Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20, 61-86.
33. Lee SJ & McPherron AC (2001). Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98, 9306-9311.
34. Lee YS & Lee SJ (2013). Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2. Proc Natl Acad Sci USA 110, E3713-E3722.
35. Li R, Rosendahl A, Brodin G, Cheng AM, Ahgren A, Sundquist C, Kulkarni S, Pawson T, Heldin CH & Heuchel RL (2006). Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol 176, 6777-6784.
36. Li ZB, Kollias HD & Wagner KR (2008). Myostatin directly regulates skeletal muscle fibrosis. J Biol Chem 283, 19371-19378.
37. Liu D, Black BL & Derynck R (2001). TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 15, 2950-2966.
38. Liu GX, Li YQ, Huang XR, Wei L, Chen HY, Shi YJ, Heuchel RL & Lan HY (2013). Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NF.kappaB-dependent mechanisms in mice. PloS ONE 8, e53573.
39. McCroskery S, Thomas M, Maxwell L, Sharma M & Kambadur R (2003). Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162, 1135-1147.
40. McPherron AC, Lawler AM & Lee SJ (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90.
41. Méndez JKA (1960). Density and composition of mammalian muscle. Metab Clin Exp 9, 184-188.
42. Miciak JJ, Warsing LC, Tibbs ME, Jasper JR, Jampel SB, Malik FI, Tankersley C & Wagner KR (2013). Fast skeletal muscle troponin activator in the dy2j muscular dystrophy model. Muscle Nerve 48, 279-285.
43. Miyake T, Alli NS & McDermott JC (2010). Nuclear function of Smad7 promotes myogenesis. Mol Cell Biol 30, 722-735.
44. Morine KJ, Bish LT, Selsby JT, Gazzara JA, Pendrak K, Sleeper MM, Barton ER, Lee SJ & Sweeney HL (2010). Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy. Muscle Nerve 42, 722-730.
45. Perry RL, Yang C, Soora N, Salma J, Marback M, Naghibi L, Ilyas H, Chan J, Gordon JW & McDermott JC (2009). Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression. Mol Cell Biol 29, 3355-3366.
46. Qiao C, Li J, Jiang J, Zhu X, Wang B, Li J & Xiao X (2008). Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 19, 241-254.
47. Rasband WS (1997-2014). ImageJ. US National Institutes of Health, Bethesda, MD.
48. Rayavarapu S, Vander Meulen JH, Gordish-Dressman H, Hoffman EP, Nagaraju K & Knoblach SM (2010). Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype. PloS ONE 5, e12981.
49. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ & Attisano L (2003). Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 23, 7230-7242.
50. Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hoque A, Fielder TJ & Gonzalez-Cadavid NF (2003). Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Cell Physiol 285, E876-E888.
51. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R & Sandri M (2009). Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296, C1248-C1257.
52. Tang Y, Liu Z, Zhao L, Clemens TL & Cao X (2008). Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J Biol Chem 283, 23956-23963.
53. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J & Kambadur R (2000). Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275, 40235-40243.
54. Tojo M, Takebe A, Takahashi S, Tanaka K, Imamura T, Miyazono K & Chiba T (2012). Smad7-deficient mice show growth retardation with reduced viability. J Biol Chem 151, 621-631.
55. Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S & Glass DJ (2009). Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296, C1258-C1270.
56. Ulloa L, Doody J & Massague J (1999). Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397, 710-713.
57. Verrecchia F, Chu ML & Mauviel A (2001). Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276, 17058-17062.
58. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER & Mendell JR (2008). A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63, 561-571.
59. Wagner KR, Liu X, Chang X & Allen RE (2005). Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 102, 2519-2524.
60. Wagner KR, McPherron AC, Winik N & Lee SJ (2002). Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 52, 832-836.
61. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L & Wolfman NM (2003). Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300, 965-971.
62. Wong J, Armour E, Kazanzides P, Iordachita I, Tryggestad E, Deng H, Matinfar M, Kennedy C, Liu Z, Chan T, Gray O, Verhaegen F, McNutt T, Ford E & DeWeese TL (2008). High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities. Int J Radiat Oncol Biol Phys 71, 1591-1599.
63. Wu H, Naya FJ, McKinsey TA, Mercer B, Shelton JM, Chin ER, Simard AR, Michel RN, Bassel-Duby R, Olson EN & Williams RS (2000). MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 19, 1963-1973.
64. Zerrate MC, Pletnikov M, Connors SL, Vargas DL, Seidler FJ, Zimmerman AW, Slotkin TA & Pardo CA (2007). Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther 322, 16-22.
65. Zhu J, Li Y, Lu A, Gharaibeh B, Ma J, Kobayashi T, Quintero AJ & Huard J (2011). Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol 179, 915-930.
66. Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, Nozaki M, Branca MF & Huard J (2007). Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem 282, 25852-25863.
67. Zhu X, Topouzis S, Liang LF & Stotish RL (2004). Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26, 262-272.
68. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM & Lee SJ (2002). Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488.